期刊文献+

肥胖儿童非酒精性脂肪肝炎发病状况及机制探讨 被引量:18

Nonalcoholic steatohepatitis in obese children:the prevalence and possible mechanism
下载PDF
导出
摘要 目的:观察不同程度肥胖儿童非酒精性脂肪肝炎(NASH)的发病状况,探讨其可能的发病机制。方法:123例体质指数(BMI)≥23的7~16岁的单纯性肥胖儿童,按BMI不同分为3组:BMI≥30组34例;25≤BMI〈30组57例;23≤BMI〈25组32例。分别检测肝脏(B超),血转氨酶、甘油三酯、胆固醇、血尿酸,以及空腹血糖/空腹血胰岛素(FGIR)比值。对其中24例怀疑合并良性黑棘皮病的患儿行皮肤病理活检,分析NASH与良性黑棘皮病的关系。结果:123例患儿中B超发现肝脂肪病变的有99例(80.49%),诊断为NASH的54例(43.90%)。BMI≥30组脂肪肝炎和良性黑棘皮病的发生率及FGIR〈7者均明显高于其他两组(P〈0.01)。在54例NASH患儿中20例伴良性黑棘皮病(37.04%),其发生高脂血症、胰岛素抵抗的概率及BMI值均明显高于24例不伴脂肪肝的肥胖儿童。经相关分析,ALT和AST与BMI、血胆固醇、血甘油三酯、FGIR有相关性(rs=0.413、0.290、0.379、-0.477,P〈0.01;rs=0.359、0.349、0.348、-0.369,P〈0.01)。结论:BMI≥30是肥胖儿童发生NASH的高危因素。NASH患儿中良性黑棘皮病发生率高,其严重的脂代谢紊乱及胰岛素抵抗可能是参与NASH发病的主要机制。 Objective: To investigate the prevalence of nonalcoholic steatohepatitis (NASH) in obese children and its possible mechanism, Methods: Three subgroups were classified according to their body mass index (BMI) in 123 obese children with BMI over 23 aged 7 to 16:34 cases with BMI≥30 group;57 cases with 25≤BMI(30 group; 32 cases with 23≤BMI(25 group. Ultrasonographic and biochemical parameters including serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), serum cholesterol, serum triglyceride, serum uric acid and free glucose to free insulin ratio (FGIR) were assayed. Twenty four children suspected as benign acanthosis nigricans underwent skin biopsy and its association with nonalcoholic Fifty-four children diagnosed as NASH showed significantly higher incidence of hyperlipidemia, insulin resistance and higher body mass index as compared with 24 subjects without fatty liver changes. In 54 NASH children, 20 (37. 04%) had benign acanthosis nigricans. By bivariate analysis,ALT and AST were correlated well with BMI,cholesterol,triglyceride and FGIR (rs= 0.413, 0.290, 0.379, -0.477, P〈0.01; rs= 0.359, 0.349, 0.348, -0.369, P〈0.01). Conclusion: There is a high prevalence of nonalcoholic steatohepatitis in simple obese children and high incidence of benign acanthosis nigricans in NASH subjects. BMI≥30 is a high risk factor of being NASH. Severe disturbance of lipid metabolism and insulin resistance may be involved in the mechanism of NASH.
出处 《浙江大学学报(医学版)》 CAS CSCD 2006年第1期64-68,共5页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省医药卫生优秀科技人才专项基金(491040-W10317)
关键词 脂肪肝/病因学 脂肪肝/诊断 棘皮症 胰岛素抗药性 肥胖症 Fatty liver/etiol Fatty liver/diag Acanthosis nigricans Insulin resistance Obesity
  • 相关文献

参考文献11

  • 1LAVINE J E.Vitamin E treatment of nonal-coholic steatohepatitis in children:a pilot study[J].J Pediatr,2000,136(6):734-738.
  • 2FRANZESE A,VAJRO P,ARGENZIANO A,et al.Liver involvement in obese children:ultra-sonography and liver enzyme levels at diagnosis and during follow-up in an Italian population[J].Dig Dis Sci,1997,42(7):1 428-1 432.
  • 3BERGOMI A,LUGHETTI L,CORCIULO N,et al.Italian multicenter study on liver damage in pediatric obesity[J].Int J Obes Relat Metab Disord,1998,22(suppl 4):s22-29.
  • 4TAZAWA Y,NOGUCHI H,NISHIOMIYA F,et al.Serum alanine aminotransferase activity in obese children[J].Acta Paediatr,1997,86(3):238-241.
  • 5RASHID M,ROBERTS E A.Nonalcoholic stea-tohepatitis in children[J].J Pediatr Gastro-enterol Nutr,2000,30(1):48-53.
  • 6TOMINAGA K,KURATA J H,CHEN Y K,et al.Prevalence of fatty liver in Japanese children and relationship to obesity:an epidemiological ultrasonographic survey[J].Dig Dis Sci,1995,40(9):2 002-2 009.
  • 7ANGULO P,KEACH J C,BATTS K P,et al.Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis[J].Hepatology,1999,30(6):1 356-1 362.
  • 8HARRISON S A,DI BISCEGLIE A M.Advan-ces in the understanding and treatment of nonalcoholic fatty liver disease[J].Drug,2003,63(22):2 379-2 394.
  • 9MIRIAM E S,ALEXANDRA M M,DONALD J M,et al.Comparison of simple measures of insulin sensitivity in young girls with premature adrenarche:the fasting glucose to insulin ratio may be a simple and useful measure[J].J Clin Endocrinol Metab,2001,86(6):2 863-2 868.
  • 10STUART C A,DRISCOLL M S,LUND-QUIST K F,et al.Acanthosis nigricans[J].J Basic Clin Physiol Pharmacol,1998,9(2-4):407-418.

同被引文献142

引证文献18

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部